| |
|
 |
DGRA INTRANET |
 |
| |
| |
 |
|
| Hier
finden Sie interne Informationen für Mitglieder.
|
 |
|
| |
|
 |
GESCHÄFTSADRESSE: |
 |
| |
| |
 |
|
Schedestrasse 9
D-53113 Bonn
Tel.: 0228 / 368264-6
Fax: 0228 / 368264-7
E-Mail: info@dgra.de
|
 |
|
|
|
 |
| DGRA-STUDIENPREIS |
 |
 |
DGRA Studienpreisverleihung 2009 |
| |
Fotos von der Urkunden- und Preisverleihung, März 2010 Pressemitteilung zur Urkundenverleihung
Master-Thesis der Preisträger/-innen:
Dr. Christine Kriete Peculiarities and Challenges of Herbal Medicinal Products - Assessment of Herbal Medicinal Products within the Regulatory Environments of the European Community and the United States
Claudia Keupp Portfolio strategies of cytotoxic drugs – current topics of regulatory economy
Dr. Susanne Vambrie Regulatory Requirements for the Clinical Development of New Therapies for the Treatment of Alzheimer’s Disease
Anna Paulina Paul The Polish Pharmaceutical Law – Strenghts and Weaknesses 5 Years after Accession to the European Union. Analysis
Viola Hieble-Gerhard Risk-based management of GMP audits within the context of supplier relationships – an approach for a medium-sized pharmaceutical company
Dr. Corinna Weidt A regulatory guidance on achieving and maintaining proof of compliance with an agreed PIP
|
| |
|
 |
DGRA Studienpreisverleihung 2008 |
| |
Fotos von der Urkunden- und Preisverleihung, Februar 2009 Pressemitteilung zur 6. Urkundenverleihung
Master-Thesis der Preisträger/-innen:
Mariela Becker Experiences with the New Decentralised Procedure - Changes, Limits, Perspectives
Dr. Ursula Beikert REACH - How does it affect the pharmaceutical industry? Consideration of the issue for a medium-sized enterprise
Dr. Christian Kutzleb Comparison of the Regulatory Environment to Authorise so-called Combination Products Consisting of a Drug and a Medical Device in the US and the EU
Dr. Barbara Römer 2001/20/EC - A European Directive? Major Regulatory Objectives for a real Harmonisation in Europe
Nadine Stöckl Optimisation of Master File Procedures for Biologics: Comparison of Master File Procedures - EU and USA
Dr. Matthias Dormeyer Regulatory Strategies and Practical Aspects for the Development and Authorisation of Orphan Medicinal Products in the European Union
|
| |
|
 |
DGRA Studienpreisverleihung 2007 |
| |
Fotos von der Urkunden- und Preisverleihung, Februar 2008
Master-Thesis der Preisträgerinnen:
Tanja Weber (Studiengang 2004/2005) A Step Beyond Module 3 of Biodegradable Implants
Dr. Ursula Schickel (Studiengang 2004/2005) The impact of the revised EU-legislation concerning particular needs of blind and partially-sighted patients and user testing – a challenge for pharmaceutical companies with focus on Germany
|
| |
|
 |
DGRA Studienpreisverleihung 2006 |
| |
Fotos von der Urkunden- und Preisverleihung, Februar 2007
Master-Thesis der Preisträgerinnen:
Dr. Sibylle Kaiser (Studiengang 2002/2003): Tissue engineered products – Need and requirements for an appropriate harmonised EU regulatory framework
Dr. Astrid Weyermann (Studiengang 2004/2005): Labelling requirements for investigational medicinal products in multinational studies: bureaucratic cost driver or added value?
Dr. Silke Jung (Studiengang 2003/2004): New drug substances with abuse potential: Points to consider for the development and marketing
Dr. Tatyana Benicheva-Dimitrova (Studiengang 2004/2005): Challenges For The Pharmaceutical Legislative Implementation In Terms Of An Accelerated Market Access After October 2005
|
| |
|
 |
DGRA Studienpreisverleihung 2005 |
| |
Urkunden (PDF-Datei, 60 KB) Foto von der Urkunden- und Preisverleihung, November 2005
Master-Thesis der Preisträger/-innen:
Dr. Arno Wiehe (Studiengang 2003/2004): Data protection for the development of known drug substances - Changes with the review of EU legislation
Dr. Oliver Weyand (Studiengang 2003/2004): Generic Medicinal Product Portfolio from a Regulatory and Business Development point of view
Andrea Hörner (Studiengang 2003/2004): Describe the CADREAC-procedure for a product which was authorized via mutual recognition procedure in the EU and ...
Dr. Karen Rosenkranz (Studiengang 2002/2003): Regulatory strategies for life-cycle management of chemical defined cytostatic drugs with regard to the new pharmaceutical legislation
Dr. Ulrike Domack (Studiengang 2002/2003): Regulatory Science on Orphan Drug Application within Paediatric Field |
| |
|
 |
DGRA-Studienpreis 2004 |
| |
Fotos von der Preisverleihung, Juni 2004
Master-Thesis der Preisträger/-innen:
Dr. Anja Mecklenburg (Studiengang 2001/2002): Strategies for Carcinogenicity Testing of Human Pharmaceuticals
Dr. Michael Berntgen (Studiengang 2001/2002): Exploring Paediatric Indications for Off-patent Drug Substances - Strategic Input of Regulatory Affairs
Birgit Moetamedi (Studiengang 2001/2002): Comparison and assessment of the current EU-Variation Regulations 541/95 and 542/95 and the revised new EU-Variation Regulations 1084/2003 and 1085/2003 |
| |
|
 |
DGRA-Studienpreis 2002 |
| |
Vortrag der Preisträgerin Dr. Andrea Derix: Gewährleistung der Schutzrechte in der EU-Erweiterung (PDF-Datei, 826 KB)
Fotos von der Urkunden- und Preisverleihung, Februar 2003 |
| |
|
 |
DGRA-Studienpreis 2001 |
| |
Pressemitteilung vom 28.11.2001: DGRA-Studienpreis 2001 verliehen
Vortrag des Preisträgers Dr. Jürgen-Hans Schmidt: From study protocol to final report (PDF-Datei, 95 KB)
Fotos von der Urkunden- und Preisverleihung, November 2001 |
|
| |
 |
 |
|
|
|
 |
|
|
 |
|
|
 |
|
|
 |
© 2009, DGRA e.V.
Letzte Aktualisierung am: Mittwoch, 09.06.2010 |
|
|